We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.7B
AUM Growth
+$354M
Cap. Flow
+$180M
Cap. Flow %
4.86%
Top 10 Hldgs %
45.26%
Holding
381
New
32
Increased
193
Reduced
114
Closed
15

Top Buys

Rank Stock Value
1
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$120M
2
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$42.3M
3
XLI icon
State Street Industrial Select Sector SPDR ETF
XLI
+$29.4M
4
HPE icon
Hewlett Packard
HPE
+$16M
5
LULU icon
lululemon athletica
LULU
+$15.4M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$17.9M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$15.5M
3
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$11.8M
4
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$10.6M
5
XLB icon
State Street Materials Select Sector SPDR ETF
XLB
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 13.99%
2 Healthcare 6.23%
3 Financials 4.09%
4 Communication Services 2.89%
5 Industrials 2.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHW icon
351
Sherwin-Williams
SHW
$86B
$202K 0.01%
+530
New +$185K
ET icon
352
Energy Transfer Partners
ET
$69.8B
$200K 0.01%
+12,474
New +$201K
CRF
353
Cornerstone Total Return Fund
CRF
$1.15B
$197K 0.01%
24,850
+851
+4% +$6.49K
IRWD icon
354
Ironwood Pharmaceuticals
IRWD
$728M
$176K ﹤0.01%
42,675
– –
NAK
355
Northern Dynasty Minerals
NAK
$818M
$99.1K ﹤0.01%
298,950
– –
HRTX icon
356
Heron Therapeutics
HRTX
$96.8M
$95.2K ﹤0.01%
47,863
– –
MRNS
357
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$59.2K ﹤0.01%
33,609
– –
GGN
358
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$770M
$46.7K ﹤0.01%
+10,902
New +$45.2K
IBRX icon
359
ImmunityBio
IBRX
$7.49B
$37.2K ﹤0.01%
10,000
– –
RBBN icon
360
Ribbon Communications
RBBN
$379M
$32.6K ﹤0.01%
10,030
– –
GLDG
361
GoldMining Inc
GLDG
$190M
$32K ﹤0.01%
+34,000
New +$30.6K
MRSN
362
DELISTED
Mersana Therapeutics
MRSN
$28.3K ﹤0.01%
600
– –
REKR icon
363
Rekor Systems
REKR
$90M
$19.5K ﹤0.01%
16,500
– –
RGLS
364
DELISTED
Regulus Therapeutics
RGLS
$17.2K ﹤0.01%
10,975
– –
FUBO icon
365
FuboTV Inc
FUBO
$283M
$14.2K ﹤0.01%
833
– –
VOR icon
366
Vor Biopharma
VOR
$1.16B
$10.6K ﹤0.01%
757
– –
EOSE icon
367
Eos Energy Enterprises
EOSE
$1.36B
– –
-40,000
Closed -$50.8K
GLAD icon
368
Gladstone Capital
GLAD
$430M
– –
-15,196
Closed -$354K
HBAN icon
369
Huntington Bancshares
HBAN
$35.1B
– –
-12,818
Closed -$169K
IEI icon
370
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
– –
-2,739
Closed -$316K
ISPC icon
371
iSpecimen
ISPC
$2.89M
– –
-39
Closed -$9.52K
ITA icon
372
iShares US Aerospace & Defense ETF
ITA
$14.4B
– –
-1,783
Closed -$235K
JPST icon
373
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
– –
-4,955
Closed -$250K
LNC icon
374
Lincoln National
LNC
$8.82B
– –
-6,514
Closed -$203K
LPG icon
375
Dorian LPG
LPG
$1.97B
– –
-5,000
Closed -$210K
12 13 14
15
16

Similar funds

DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Grimes & Company's Q3 2024 Portfolio in Review

As of Q3 2024, Grimes & Company held 381 positions worth $3.7B, up 11% from $3.34B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Grimes & Company deployed $180M of net new capital in Q3 2024, opening 32 new positions and adding to 193 existing holdings. Its largest new stake was State Street Industrial Select Sector SPDR ETF: 231,081 shares worth $31.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was RTX Corp, an estimated $17.9M trimmed.

  • Grimes & Company's largest Q3 2024 buy was State Street Industrial Select Sector SPDR ETF: 231,081 shares worth $31.3M.
  • Grimes & Company added most to Vanguard Morningstar Small-Cap ETF in Q3 2024, an estimated $120M increase.
  • Grimes & Company's biggest Q3 2024 reduction was RTX Corp, cutting an estimated $17.9M.
  • Grimes & Company fully exited iShares 0-1 Year Treasury Bond ETF in Q3 2024, selling an estimated $454K.
  • Grimes & Company's ten largest holdings make up 45% of its $3.7B portfolio in Q3 2024.
  • Grimes & Company opened 32 new positions and closed 15 in Q3 2024.
  • Grimes & Company's portfolio value rose 11% quarter-over-quarter to $3.7B.

Based on Grimes & Company's 13F filing for Q3 2024, filed 22 Oct 2024.